Literature DB >> 19220466

Serum resistance and biofilm formation in clinical isolates of Acinetobacter baumannii.

Lauren B King1, Edwin Swiatlo, Andrea Swiatlo, Larry S McDaniel.   

Abstract

Acinetobacter baumannii has few known virulence factors and yet causes a variety of opportunistic infections. Many gram-negative bacteria are directly killed by complement, but we hypothesized that A. baumannii would be resistant to serum killing. A serum bactericidal assay assessed the resistance of seven A. baumannii isolates to serum killing, and C2-deficient serum was used to examine its activation of the alternative pathway. Flow cytometry was utilized to determine whether complement regulator factor H (FH) was bound by A. baumannii, and to assay C3 deposition on cells. A microtiter biofilm assay compared biofilm production among isolates. Of seven isolates, four were serum sensitive and three were serum resistant. The C2-deficient serum demonstrated that A. baumannii can activate the alternative pathway. None of the isolates bound FH. Serum-resistant strains accumulated little C3 when exposed to human serum, while sensitive strains had a high amount of surface C3 deposition. Biofilm production varied extensively among strains. Most serum-resistant isolates formed a substantial amount of biofilm, while sensitive isolates produced negligible amounts of biofilm. Our data indicate that some strains of A. baumannii are resistant to serum killing and produce biofilms and by understanding the resistance mechanisms used by this bacterium, we can further elucidate its complex pathogenicity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19220466     DOI: 10.1111/j.1574-695X.2009.00538.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  34 in total

1.  Genomic comparison of multi-drug resistant invasive and colonizing Acinetobacter baumannii isolated from diverse human body sites reveals genomic plasticity.

Authors:  Jason W Sahl; J Kristie Johnson; Anthony D Harris; Adam M Phillippy; William W Hsiao; Kerri A Thom; David A Rasko
Journal:  BMC Genomics       Date:  2011-06-04       Impact factor: 3.969

2.  Interaction of Acinetobacter baumannii 19606 and 1656-2 with Acanthamoeba castellanii.

Authors:  Migma Dorji Tamang; Shukho Kim; Sung-Min Kim; Hyun-Hee Kong; Jungmin Kim
Journal:  J Microbiol       Date:  2011-11-09       Impact factor: 3.422

Review 3.  Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options.

Authors:  Yohei Doi; Gerald L Murray; Anton Y Peleg
Journal:  Semin Respir Crit Care Med       Date:  2015-02-02       Impact factor: 3.119

4.  Cloning of ompA gene from Acinetobacter baumannii into the eukaryotic expression vector pBudCE4.1 as DNA vaccine.

Authors:  Hossein Ansari; Abbas Doosti; Mohammad Kargar; Mahdi Bijanzadeh; Mojtaba Jaafarinia
Journal:  Indian J Microbiol       Date:  2018-02-09       Impact factor: 2.461

5.  Current advances and challenges in the development of Acinetobacter vaccines.

Authors:  Wangxue Chen
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  Growth in glucose-based medium and exposure to subinhibitory concentrations of imipenem induce biofilm formation in a multidrug-resistant clinical isolate of Acinetobacter baumannii.

Authors:  Elisabetta Nucleo; Laura Steffanoni; Giulia Fugazza; Roberta Migliavacca; Ernesto Giacobone; Antonella Navarra; Laura Pagani; Paolo Landini
Journal:  BMC Microbiol       Date:  2009-12-22       Impact factor: 3.605

7.  Microbiological features and clinical impact of the type VI secretion system (T6SS) in Acinetobacter baumannii isolates causing bacteremia.

Authors:  Jungok Kim; Ji-Young Lee; Haejeong Lee; Ji Young Choi; Dae Hun Kim; Yu Mi Wi; Kyong Ran Peck; Kwan Soo Ko
Journal:  Virulence       Date:  2017-04-27       Impact factor: 5.882

8.  Outer membrane Protein A plays a role in pathogenesis of Acinetobacter nosocomialis.

Authors:  Sang Woo Kim; Man Hwan Oh; So Hyun Jun; Hyejin Jeon; Seung Il Kim; Kwangho Kim; Yoo Chul Lee; Je Chul Lee
Journal:  Virulence       Date:  2016-01-13       Impact factor: 5.882

9.  Genomic and physiological analyses of an indigenous strain, Enterococcus faecium 17OM39.

Authors:  Vikas C Ghattargi; Yogesh S Nimonkar; Shaunak A Burse; Dimple Davray; Shreyas V Kumbhare; Sudarshan A Shetty; Meghana A Gaikwad; Mangesh V Suryavanshi; Swapnil P Doijad; Bhimashankar Utage; Om Prakash Sharma; Yogesh S Shouche; Bharati S Meti; Shrikant P Pawar
Journal:  Funct Integr Genomics       Date:  2018-03-19       Impact factor: 3.410

10.  Complexity of Complement Resistance Factors Expressed by Acinetobacter baumannii Needed for Survival in Human Serum.

Authors:  Amaro F Sanchez-Larrayoz; Noha M Elhosseiny; Marc G Chevrette; Yang Fu; Peter Giunta; Raúl G Spallanzani; Keerthikka Ravi; Gerald B Pier; Stephen Lory; Tomás Maira-Litrán
Journal:  J Immunol       Date:  2017-08-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.